ArticleDiscover oncology2025
Graph neural network-based multi-label classification of breast cancer using multiparametric MRI and clinical features.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Colposcopic Imaging Carries Most of the Signal: Externally Validated Tri-Modal Integration of Imaging, Vaginal Microbiome, and Coagulation-Immune Data in HPV-Associated Co-Infection.Diagnostics (Basel, Switzerland) · 2026Article
- Clinically integrated multi-modal transformer framework with cross-modal gated fusion and clinical nomogram for automated Kellgren-Lawrence grading of knee osteoarthritis on x-ray images.BMC musculoskeletal disorders · 2026Article
- Manifold-guided SMOTified dual-channel conditional GAN improving highly-imbalanced biomedical data classification.Discover oncology · 2026Article
- Novel nested conformal prediction analysis to unravel complexity in patient subtyping.Frontiers in artificial intelligence · 2026Article
- A transformer-based multi-modal fusion framework for laryngeal lesion classification using contact endoscopy.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research was done to design and evaluate a graph-based deep-learning architecture to automatically multi-label breast cancer, using multiparametric magnetic resonance imaging (MRI) data and clinical features. The general aim was to enhance the diagnostic accuracy of the key clinical activities, i.e. biomarker discovery, tumour staging, and histological grading. Three-dimensional volumetric graphs were built with the help of five different MRI modalities (Phase 1, Phase 2, Phase 3, T1, and IHSFused), and each voxel and clinical variable was a node. Attributes of the nodes were radiomic features and patient-specific clinical data whereas edges represented relationships by spatial proximity and intensity. Graph structure processing was done using a Graph Isomorphism Network (GIN), which gradually optimised node embeddings by aggregating neighbourhoods. The multi-label classification focused on the HER2 status, TNM stage (Tumour Size, Node involvement, Metastasis) and histological grade elements (Tubule formation, Mitotic count, Nuclear pleomorphism). Cross-Entropy loss and Adam optimiser were used to train the model, and Synthetic Minority Over-Sampling Technique (SMOTE) was used to balance the distribution of classes. The protocol of cross-validation was used five times to be robust and performance measures were provided in terms of accuracy, precision, recall, F1-score, and confusion matrices. The t-Stochastic Neighbor Embedding (t-SNE) visualisations were used to assess the feature separability. The model achieved high accuracy in HER2 (up to 91.42%) and Tubule grade (up to 91.83%), moderate performance in Tumor Size (70–72%), Nodes (82–84%), and Metastasis (80–83%), and lower accuracy in nuclear grade (64–68%). Confusion matrices showed minimal misclassification in high-performing labels and greater variability in lower-performing ones. t-SNE plots confirmed effective feature separation for HER2 and Tubule, with overlap noted in Nuclear. These results indicate the possibilities of volumetric graph-based learning to provide full classification of breast cancer and its importance in improving precision diagnostics with the help of artificial intelligence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.